Heart failure guidelines, performance measures, and the practice of medicine: mind the gap.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Journal of Cardiac Failure

• Publication date

  2010-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.CARDFAIL.2010.08.006PMID 21229805
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Implantable cardiac device procedures in older patients: use and in-hospital outcomes.

  2010cited by this paper
• Evidence-based heart failure performance measures and clinical outcomes: a systematic review.

  2010cited by this paper
• Relationship between early physician follow-up and 30-day readmission among Medicare beneficiaries hospitalized for heart failure.

  2010cited by this paper
• Congestive Heart Failure Performance Measures: Does Adherence Impact Early Unplanned Hospital Readmissions?

  2010cited by this paper
• Are implanted defibrillators effective therapy in the elderly?: Asked, not answered.

  2010cited by this paper
• Effectiveness of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death in women with advanced heart failure: a meta-analysis of randomized controlled trials.

  2009cited by this paper
• Use of aldosterone antagonists in heart failure.

  2009cited by this paper
• Scientific evidence underlying the ACC/AHA clinical practice guidelines.

  2009cited by this paper
• Canadian Cardiovascular Society Consensus Conference guidelines on heart failure--2008 update: best practices for the transition of care of heart failure patients, and the recognition, investigation and treatment of cardiomyopathies.

  2008cited by this paper
• Exploring the potential synergistic action of spironolactone on nitric oxide-enhancing therapy: insights from the African-American Heart Failure Trial.

  2008cited by this paper
• The impact of patient-specific quality-of-care report cards on guideline adherence in heart failure.

  2007cited by this paper
• Improving the use of evidence-based heart failure therapies in the outpatient setting: the IMPROVE HF performance improvement registry.

  2007cited by this paper
• Public reporting and pay for performance in hospital quality improvement.

  2007cited by this paper
• HFSA 2006 comprehensive heart failure practice guideline

  2006cited by this paper
• ACC/AHA Clinical Performance Measures for Adults with Chronic Heart Failure: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Heart Failure Clinical Performance Measures): endorsed by the Heart Failure Society

  2005cited by this paper
• Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF): rationale and design.

  2004cited by this paper
• Paying physicians for high-quality care.

  2004cited by this paper
• Rates of Hyperkalemia after Publication of the Randomized Aldactone Evaluation Study

  2004cited by this paper
• Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction.

  2003cited by this paper
• Improving Guideline Adherence: A Randomized Trial Evaluating Strategies to Increase &bgr;-Blocker Use in Heart Failure

  2003cited by this paper
• The underutilization of cardiac medications of proven benefit, 1990 to 2002.

  2003cited by this paper
• Aligning quality and payment for heart failure care: defining the challenges.

  2003cited by this paper
• Representation of the elderly, women, and minorities in heart failure clinical trials.

  2002cited by this paper
• The COHERE Registry: hype or hope?

  2000cited by this paper
• The public release of performance data: what do we expect to gain? A review of the evidence.

  2000cited by this paper
• Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: A systematic overview of data from individual patients

  2000cited by this paper
• The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure

  2000cited by this paper
• The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators.

  1999cited by this paper
• Clinical guidelines: potential benefits, limitations, and harms of clinical guidelines.

  1999cited by this paper

• The Wider Considerations in Closing Chronic Disease Gaps – Focus on Heart Failure and Implementation

  2022cites this paper
• Cardiovascular outcomes among elderly patients with heart failure and coronary artery disease and without atrial fibrillation: a retrospective cohort study

  2019cites this paper
• Incidence, predictors and clinical management of hyperkalaemia in new users of mineralocorticoid receptor antagonists

  2018cites this paper
• Chronic obstructive pulmonary disease and long-term mortality in elderly subjects with chronic heart failure

  2017cites this paper
• Choosing Wisely® in Preventive Medicine: The American College of Preventive Medicine's Top 5 List of Recommendations.

  2016cites this paper
• Hyponatremia during hospitalization and in-hospital mortality in patients hospitalized from heart failure

  2015cites this paper
• Outcomes of Heart Failure Discharge Instructions

  2014cites this paper
• Predicting risk: developing and testing of a nomogram to predict hospitalisation in chronic heart failure (CHF- Risk Study)

  2013cites this paper
• Heart Failure Performance Measures

  2013cites this paper
• Associations between aldosterone antagonist therapy and risks of mortality and readmission among patients with heart failure and reduced ejection fraction.

  2012cites this paper
• Noncompliance With Certain Quality Indicators Is Associated With Risk-Adjusted Mortality After Stroke

  2012cites this paper
• Epinephrine for acute decompensated heart failure and low output state: friend or foe?

  2011cites this paper
• Clinical guidelines and performance measures; responsible guidance and accountability.

  2010influential citation